Home - Screening for drug candidates targeting aberrant molecular signalling

Friday, 21. November 2008

Startpage > All projects > FP6 Life Science Health > Advanced genomics and its applications for health > Application of knowledge and technologies > Rational and accelerated development of new, safer, more effective drugs > Screening for drug candidates targeting aberrant molecular signalling


		All projects


		FP6 Life Science Health


		Advanced genomics and its applications for health


		Fundamental knowledge and basic tools for functional genomics


		Application of knowledge and technologies


		Rational and accelerated development of new, safer, more effective drugs


		Screening for drug candidates targeting aberrant molecular signalling


		Microdosing' studies to gain enhanced absorption, distribution, metabolism, excretion (ADME)


		Targeted delivery of protein-based drugs (especially orientated towards involvement of SMEs)


		Development of new diagnostics


		Development and testing of new preventive and therapeutic tools


		Combating major diseases


		Specific support actions across thematic priority 1


		FP6 Information society technologies


		FP6 Others


		FP5 Life Quality


		About the region


		Thematic areas


		IFR


		About European projects

Screening for drug candidates targeting aberrant molecular signalling in protein phosphorylation pathways

1 Projects related to Screening for drug candidates targeting aberrant molecular signalling
sorted alphabetically			1 / 1


PRO-KINASERESEARCH - Protein kinases - Novel Drug Targets of Post Genomic Era (FP6-LIFESCIHEALTH)
Date: 2004-03-01 - 2009-02-28

1

SEARCH

Advanced Search

OVERVIEWS

Sitemap

Organisation List

Person List

INFOBOX (0/0)

show all


Your infobox is empty

Powered by AVERIS